Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IPI-926 in Myelofibrosis
NCT01371617Phase 2Completed
- Sponsor
- Infinity Pharmaceuticals, Inc.
- Start
- Oct 2011
- Primary completion
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of patidegib in myelofibrosis (MF), sponsored by Infinity Pharmaceuticals, Inc.. Started Oct 2011; status: completed.
02
Drugs
patidegib
03
Conditions
myelofibrosis (MF)
Beyond the preview
Go deeper on NCT01371617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01371617.